Delivery Order SPE2DB25D3001-SPE2DB25FQUTM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of VAXNEUVANCE 0.5 ML syringes valued at $20,438.65 with a firm fixed price contract type. This order is expected to be completed by July 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through a competitive process with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes valued at $5,552.15 on May 28, 2025, with an ultimate completion date of May 29, 2025. This competitive, firm fixed-price delivery order represents a non-set-aside award for pneumococcal vaccine supply to support federal medical procurement needs. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $13,703.90 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vaxneuvance 0.5 mL syringes valued at $20,502.36. This firm fixed-price delivery order, which is set to conclude on September 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a $10,638.89 delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The delivery order represents pharmaceutical procurement to support federal medical supply...
- The Defense Logistics Agency awarded a $1,791.63 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, which is not set-aside, is scheduled for completion by September 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order valued at $46,657.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $48,271.25 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes, with a completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQUTMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,482.56 to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes on June 18, 2025, with a completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating open competition among qualified vendors. This delivery order is a child action under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for Defense Health Agency and other government healthcare systems, making this specific vaccine delivery order consistent with the company's broader mission to supply essential medical products across military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/18/25 |